Literature DB >> 24131661

A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.

D W Geale1, P V Barnett2, G W Clarke3, J Davis4, T R Kasari5.   

Abstract

For countries with OIE status, FMD free country where vaccination is not practised, vaccinate-to-live policies have a significant economic disincentive as the trade restriction waiting period is double that of vaccinate-to-die policies. The disposal of healthy vaccinated animals strictly for the purpose of regaining markets with debatable scientific justification is a global concern. The feasibility of aligning the waiting periods to facilitate vaccinate-to-live is explored. The first article of this two-part review (Barnett et al., 2015) explored the qualities of higher potency Foot-and-Mouth Disease (FMD) vaccines, performance of differentiating infected from vaccinated animals (DIVA) diagnostic assays particularly in vaccinates and carriers, as well as aspects of current limitations of post-outbreak surveillance. Here, the history behind the OIE waiting periods for FMD free status is reviewed as well as whether the risk of vaccinated animals and their subsequent products differ appreciably at 3 versus 6 months. It is concluded that alignment is feasible for vaccinate-to-live using higher potency FMD vaccines within the current OIE waiting period framework of 3 and 6 months blocks of time. These waiting periods reflect precedence, historical practicalities and considered expert opinion rather than a specific scientific rationale. The future lies in updated epidemiological and diagnostic technology to establish an acceptable level of statistical certainty for surveillance or target probability of freedom of FMDV (infection or circulation) not time restricted waiting periods. The OIE Terrestrial Code limits trade from a FMD free country where vaccination is not practiced to animal products and live non-vaccinated animals. The risk of FMDV in products derived from higher potency vaccinated animals is appreciably less than for countries with infected FMD status or even from a FMD free country where vaccination is practised for which the Code has Articles with guidelines for safe trade with time restrictions of 3 months or less. All these presume that key requirements in the implementation of emergency vaccination including appropriate vaccine match, vaccine application, susceptible population coverage, etc. are addressed. © Her Majesty the Queen in Right of Canada 2013 Reproduced with the permission of the Minister of Agriculture.

Entities:  

Keywords:  Foot-and-Mouth disease; OIE Terrestrial Code waiting periods; animal products; emergency vaccination; higher potency vaccine; international trade

Mesh:

Year:  2013        PMID: 24131661     DOI: 10.1111/tbed.12165

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  11 in total

1.  Modernizing Canada's foot and mouth disease response plan.

Authors:  Murray Gillies
Journal:  Can Vet J       Date:  2018-08       Impact factor: 1.008

2.  Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.

Authors:  Devendra K Rai; Fayna Diaz-San Segundo; Grace Campagnola; Anna Keith; Elizabeth A Schafer; Anna Kloc; Teresa de Los Santos; Olve Peersen; Elizabeth Rieder
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

3.  Assessing the Economic Impact of Vaccine Availability When Controlling Foot and Mouth Disease Outbreaks.

Authors:  Thibaud Porphyre; Karl M Rich; Harriet K Auty
Journal:  Front Vet Sci       Date:  2018-03-13

4.  Comparative evaluation of two ELISA kits for detecting antibodies to a nonstructural protein of foot-and-mouth disease virus using serum samples collected from naturally and experimentally infected cows.

Authors:  Katsuhiko Fukai; Tatsuya Nishi; Nobuaki Shimada; Kazuki Morioka; Manabu Yamada; Kazuo Yoshida; Makoto Yamakawa
Journal:  J Vet Med Sci       Date:  2018-08-21       Impact factor: 1.267

5.  Management strategies for vaccinated animals after an outbreak of foot-and-mouth disease and the impact on return to trade.

Authors:  Richard Bradhurst; Graeme Garner; Iain East; Clare Death; Aaron Dodd; Tom Kompas
Journal:  PLoS One       Date:  2019-10-11       Impact factor: 3.240

Review 6.  Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health.

Authors:  Mar Forner; Rodrigo Cañas-Arranz; Sira Defaus; Patricia de León; Miguel Rodríguez-Pulido; Llilianne Ganges; Esther Blanco; Francisco Sobrino; David Andreu
Journal:  Vaccines (Basel)       Date:  2021-05-08

7.  Further evaluation of an ELISA kit for detection of antibodies to a nonstructural protein of foot-and-mouth disease virus.

Authors:  Katsuhiko Fukai; Tatsuya Nishi; Kazuki Morioka; Manabu Yamada; Kazuo Yoshida; Rie Kitano; Reiko Yamazoe; Toru Kanno
Journal:  J Vet Med Sci       Date:  2015-10-25       Impact factor: 1.267

8.  Complexities in Isolation and Purification of Multiple Viruses from Mixed Viral Infections: Viral Interference, Persistence and Exclusion.

Authors:  Naveen Kumar; Sanjay Barua; Thachamvally Riyesh; Kundan K Chaubey; Krishan Dutt Rawat; Nitin Khandelwal; Anil K Mishra; Nitika Sharma; Surender S Chandel; Shalini Sharma; Manoj K Singh; Dinesh K Sharma; Shoor V Singh; Bhupendra N Tripathi
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

9.  Construction and characterization of recombinant human adenovirus type 5 expressing foot-and-mouth disease virus capsid proteins of Indian vaccine strain, O/IND/R2/75.

Authors:  Ramesh Kumar; B P Sreenivasa; R P Tamilselvan
Journal:  Vet World       Date:  2015-02-10

10.  Transmission of Foot-and-Mouth Disease from Persistently Infected Carrier Cattle to Naive Cattle via Transfer of Oropharyngeal Fluid.

Authors:  Jonathan Arzt; Graham J Belsham; Louise Lohse; Anette Bøtner; Carolina Stenfeldt
Journal:  mSphere       Date:  2018-09-12       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.